Skip to content
Wenlo
Sign in
← Markets

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares

144NBIXFiled Nov 17, 2026, 11:29 AM ET

About this filing

Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Nov 17, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012
Relationship
Director
Shares to sell
15,000
Market value
$2,479,650.00
Approximate sale date
Nov 17, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired
Nov 17, 2026 · Exercise of Stock Options

Rule 10b5-1 plan · adopted Aug 18, 2026

More NBIX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.